This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLSALICYLIC ACID ATENOLOL Medline Plus Health Information Transient Ischemic Attack

Stroke, Vol 19, 512-517, Copyright © 1988 by American Heart Association

ARTICLES

The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. The Dutch TIA Study Group

We describe the background, design, and organization of a double-blind clinical trial in patients with transient ischemic attacks or nondisabling stroke in more than 60 hospitals in The Netherlands. Two different therapeutic comparisons are made by double randomization: 30 mg vs. 300 mg acetylsalicylic acid, and 50 mg atenolol vs. placebo. For the diagnosis, a checklist has been used on which the time course and the nature of the symptoms are recorded in plain language. The analysis will primarily assess death and disability from all causes, with disability measured using a modified Rankin scale. Secondary end points will be vascular death, nonfatal stroke, nonfatal myocardial infarction, and retinal infarction. The study will last for a minimum of 3 years and should involve at least 2,500 patients. More than 1,100 patients were randomized in the 1st year.

This article has been cited by other articles:

				J. Pagola, M. Ribo, J. Alvarez-Sabin, M. Lange, M. Rubiera, and C. A. Molina Timing of Recanalization After Microbubble-Enhanced Intravenous Thrombolysis in Basilar Artery Occlusion Stroke, November 1, 2007; 38(11): 2931 - 2934. [Abstract] [Full Text] [PDF]

				P. H.A. Halkes, L. J. Kappelle, J. van Gijn, I. van Wijk, P. J. Koudstaal, and A. Algra Large Subcortical Infarcts: Clinical Features, Risk Factors, and Long-Term Prognosis Compared With Cortical and Small Deep Infarcts Stroke, July 1, 2006; 37(7): 1828 - 1832. [Abstract] [Full Text] [PDF]

				S. E. Vermeer, W. Sandee, A. Algra, P. J. Koudstaal, L. J. Kappelle, D. W.J. Dippel, and on behalf of the Dutch TIA Trial Study Group Impaired Glucose Tolerance Increases Stroke Risk in Nondiabetic Patients With Transient Ischemic Attack or Minor Ischemic Stroke Stroke, June 1, 2006; 37(6): 1413 - 1417. [Abstract] [Full Text] [PDF]

				M. Ribo, J. Alvarez-Sabin, J. Montaner, F. Romero, P. Delgado, M. Rubiera, R. Delgado-Mederos, and C. A. Molina Temporal Profile of Recanalization After Intravenous Tissue Plasminogen Activator: Selecting Patients for Rescue Reperfusion Techniques Stroke, April 1, 2006; 37(4): 1000 - 1004. [Abstract] [Full Text] [PDF]

				R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation, March 14, 2006; 113(10): e409 - e449. [Abstract] [Full Text] [PDF]

				R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, February 1, 2006; 37(2): 577 - 617. [Abstract] [Full Text] [PDF]

				M. Iijima, M. Yamamoto, M. Hirayama, F. Tanaka, M. Katsuno, K. Mori, H. Koike, N. Hattori, K. Arimura, M. Nakagawa, et al. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP Neurology, April 26, 2005; 64(8): 1471 - 1475. [Abstract] [Full Text] [PDF]

				M. Ribo, C. A. Molina, A. Rovira, M. Quintana, P. Delgado, J. Montaner, E. Grive, J. F. Arenillas, and J. Alvarez-Sabin Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol Stroke, March 1, 2005; 36(3): 602 - 606. [Abstract] [Full Text] [PDF]

				J. T. King Jr, J. Tsevat, and M. S. Roberts Preference-Based Quality of Life in Patients With Cerebral Aneurysms Stroke, February 1, 2005; 36(2): 303 - 309. [Abstract] [Full Text] [PDF]

				P. C. G. Simons, A. Algra, M. L. Bots, D. E. Grobbee, and Y. van der Graaf Common Carotid Intima-Media Thickness and Arterial Stiffness : Indicators of Cardiovascular Risk in High-Risk PatientsThe SMART Study (Second Manifestations of ARTerial disease) Circulation, August 31, 1999; 100(9): 951 - 957. [Abstract] [Full Text] [PDF]